UDD-71164-31220 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-09-07
Dose 1 — Pfizer-BioNTech
2021-10-15
Registered in v-safe
2021-10-15
Dose 2 — Pfizer-BioNTech
2021-10-15
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-10-16
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activities

Free text: Shortness of breath

MedDRA releases: 2024-11 · check-in free text available
2021-10-18
Survey response — days 1–6 daily, dose 2
MedDRA: Asthenia, Neck pain — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Headache, Muscle or body aches

Free text: Weakness, neck pain

MedDRA releases: 2024-11 · check-in free text available
2021-10-20
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness · Headache

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-09-07	Pfizer-BioNTech	No
2	2021-10-15	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 2

2021-10-16

Systemic reaction (other): Shortness of breath

2021-10-18

Systemic reaction (other): Weakness, neck pain

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Asthenia	·	·	✓
SRO	Dyspnoea	·	·	✓
SRO	Neck pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release